Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02140866
Other study ID # 109
Secondary ID
Status Completed
Phase N/A
First received May 2, 2014
Last updated September 19, 2017
Start date May 2014
Est. completion date May 2016

Study information

Verified date September 2017
Source Parker Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study examines whether hand exercise therapy as an add on to a compensatory intervention program focused on joint protection, assistive devices and alternative methods of doing will improve the performance of ADL tasks requiring hand function in patients with rheumatoid arthritis (RA).


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date May 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Female sex.

- Age = 18.

- Diagnosis of rheumatoid arthritis (2).

- Involvement of the hands, due to minimum one tender wrist, metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joint in one of the hands.

- Be on stable medication for at least 3 months prior to participation.

- Self-reported decreased ability to perform personal and instrumental ADL tasks involving the hands.

Exclusion Criteria:

- Significant osteoarthritis of the hand assessed at the initial examination by the rheumatologist

- Hand surgery within 6 months of study participation

- Other pain condition involving muscles and/or joints, e.g. fibromyalgia.

- Prednisolon therapy, change in dose of biological agent or start of treatment with a new biological agent within the last 3 month before study start.

- Inability to understand the information or to speak Danish

- Any other condition that in the opinion of the investigator or accessing rheumatologist puts an otherwise eligible participant at increased risk by participation or otherwise make the person unfit for participation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Hand Exercise

Compensatory Intervention Program (CIP)


Locations

Country Name City State
Denmark Copenhagen University Hospital, Frederiksberg Frederiksberg

Sponsors (6)

Lead Sponsor Collaborator
Parker Research Institute Aase and Ejnar Danielsens Foundation, Danish Association of Occupational Therapist, Danish Physiotherapy Foundation, Oak Foundation, The Danish Rheumatism Association

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Ultrasound Doppler within 2 weeks post intervention
Primary The Assessment of Motor and Process Skills (AMPS) - the motor skill scale within 2 weeks post intervention
Secondary The Assessment of Motor and Process Skills(AMPS) - the process skill scale within 2 weeks post intervention
Secondary The Activities of Daily Living Questionnaire (ADL-Q) within 2 weeks post intervention
Secondary Health Assessment Questionnaire (HAQ) within 2 weeks post intervention
Secondary Overall disease activity (DAS-28) within 2 weeks post intervention
Secondary Grip strength within 2 weeks post intervention
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4